DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,015 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $685,089 | -5.1% | 2,742 | -5.2% | 0.37% | -14.1% |
Q1 2024 | $722,190 | +7.2% | 2,892 | -0.7% | 0.43% | +1.4% |
Q4 2023 | $673,662 | -6.8% | 2,912 | 0.0% | 0.42% | -13.9% |
Q3 2023 | $722,467 | +3.4% | 2,912 | 0.0% | 0.49% | +6.1% |
Q2 2023 | $698,880 | -4.8% | 2,912 | 0.0% | 0.46% | -23.1% |
Q1 2023 | $733,940 | -5.0% | 2,912 | 0.0% | 0.60% | +24.3% |
Q4 2022 | $772,903 | +1.8% | 2,912 | -0.9% | 0.48% | -4.0% |
Q3 2022 | $759,000 | +1.9% | 2,937 | 0.0% | 0.50% | +17.1% |
Q2 2022 | $745,000 | -13.6% | 2,937 | 0.0% | 0.43% | 0.0% |
Q1 2022 | $862,000 | -10.8% | 2,937 | 0.0% | 0.43% | -11.9% |
Q4 2021 | $966,000 | +8.8% | 2,937 | +0.7% | 0.49% | -4.3% |
Q3 2021 | $888,000 | +11.8% | 2,917 | 0.0% | 0.51% | +2.6% |
Q2 2021 | $794,000 | +17.3% | 2,917 | 0.0% | 0.50% | +21.9% |
Q1 2021 | $677,000 | -6.5% | 2,917 | -3.3% | 0.41% | -26.3% |
Q4 2020 | $724,000 | – | 3,017 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |